Baycol

Do I have a case?

 

What is Baycol?

What is the problem?

Who is responsible?

What is being done?

What can you do?

FAQs

Breaking news

Resources on the web

Medical information

What is being done about Baycol injuries?

  What has been done so rar with regard to Baycol litigation?
  Are Baycol injuries being addressed internationally?

 


What has been done so far with regard to Baycol litigation?

Baycol litigation against the Bayer Pharmaceutical Division began in earnest in March 2002, when four people filed lawsuits against the company having allegedly suffered serious Baycol injuries as a result of their use of the cholesterol drug. The Baycol litigation, filed in Portland, Oregon, amounted to a total of $15 million. The basis for these Baycol injury claims was that the Bayer Pharmaceutical Division had failed to correctly raise awareness about the possible effects of Baycol, and had not warned either the government or the FDA to a sufficient extent. Of the four lawsuits, three were filed in Multnomah County Circuit Court, while the fourth piece of Baycol litigation was filed in U.S. District Court for Oregon. This is the seminal case of Baycol litigation since the drug's recall, although there are several others around the country. Defendant corporations are Bayer A.G., Bayer Corporation, GlaxoSmithKline plc, and SmithKline Beecham Corporation.

The United States District Court for Minnesota, based in Minneapolis, approved a Case Management Order to set an early deadline for moving this Baycol injury case to trial. This court presides over the National Baycol Products Liability Litigation, and so its order affects the entire nation with regard to Baycol litigation. The effects of the order included a schedule for production of relevant documentation by the prosecution and 250,000 such documents have already been produced. There are various events along the timeline, but the projected date for the official trial is some time in early 2003. An official website for the case has been established by the court, noting important updates to the trial. It can be found at
http://www.mnd.uscourts.gov.


 

 

Are Baycol injury cases being addressed internationally?
 

There is no doubt that the main focus of Baycol injury cases has been in the United States, where over 700,000 people regularly consumed the drug. However, the drug was also sold in other markets, as would be expected from a German company boasting one of the largest global market shares. The drug was withdrawn from sale concurrently, apart from Japan where it remained on shelves for two weeks longer than other markets. No other nation has yet incited Baycol litigation proceedings against the Bayer Pharmaceutical Division concerning Baycol injuries, but the lead taken by the United States is almost certain to influence similar Baycol litigation activity around the world.

$568 million of Baycol was sold during the year it was on sale. Although this accounted for only 3.5 percent of the total statin market, it still meant that 700,000 people in the U.S. used the drug, and numerous thousands of others around the world.

 


 

Do I have a Baycol injury case?
 

Philadelphia Lawyers - Pennsylvania Lawsuits at Monheit Law

Law Offices of Michael Monheit 1368 Barrowdale Road  Rydal, PA  19046
Call Us Toll Free: 866-761-1385  P: 215-840-6573  E: Michael@Monheit.com